Yukiko Niwa

1.2k total citations
41 papers, 913 citations indexed

About

Yukiko Niwa is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yukiko Niwa has authored 41 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 17 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Yukiko Niwa's work include Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (12 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Yukiko Niwa is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (12 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Yukiko Niwa collaborates with scholars based in Japan, France and United States. Yukiko Niwa's co-authors include Yasuhiro Kodera, Suguru Yamada, Michitaka Fujiwara, Tsutomu Fujii, Mitsuro Kanda, Chie Tanaka, Masamichi Hayashi, Naoki Iwata, Goro Nakayama and Daisuke Kobayashi and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Annals of Surgery.

In The Last Decade

Yukiko Niwa

38 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukiko Niwa Japan 20 405 402 380 223 134 41 913
Kohei Wakatsuki Japan 19 513 1.3× 546 1.4× 526 1.4× 155 0.7× 126 0.9× 56 1.1k
Gerd Jomrich Austria 18 405 1.0× 596 1.5× 240 0.6× 202 0.9× 131 1.0× 55 1.0k
Kojiro Eto Japan 17 437 1.1× 396 1.0× 444 1.2× 229 1.0× 174 1.3× 92 1.0k
Faik G. Uzunoǧlu Germany 15 346 0.9× 420 1.0× 310 0.8× 136 0.6× 180 1.3× 59 791
Atsushi Takeno Japan 17 471 1.2× 271 0.7× 539 1.4× 189 0.8× 80 0.6× 137 945
Yohei Nagai Japan 16 552 1.4× 338 0.8× 485 1.3× 153 0.7× 78 0.6× 57 914
Yoshiaki Sugiura Japan 14 402 1.0× 373 0.9× 286 0.8× 380 1.7× 209 1.6× 41 1.0k
Jorge Baixauli Spain 21 571 1.4× 575 1.4× 222 0.6× 158 0.7× 80 0.6× 71 1.1k
Keijiro Nozawa Japan 18 303 0.7× 677 1.7× 246 0.6× 201 0.9× 192 1.4× 70 1.0k
Pengfei Kong China 19 276 0.7× 678 1.7× 381 1.0× 174 0.8× 237 1.8× 41 1.1k

Countries citing papers authored by Yukiko Niwa

Since Specialization
Citations

This map shows the geographic impact of Yukiko Niwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukiko Niwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukiko Niwa more than expected).

Fields of papers citing papers by Yukiko Niwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukiko Niwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukiko Niwa. The network helps show where Yukiko Niwa may publish in the future.

Co-authorship network of co-authors of Yukiko Niwa

This figure shows the co-authorship network connecting the top 25 collaborators of Yukiko Niwa. A scholar is included among the top collaborators of Yukiko Niwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukiko Niwa. Yukiko Niwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katagiri, Satoshi, Yukiko Niwa, Tatsuo Araida, et al.. (2019). Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. HPB. 21. S248–S248.
2.
Yamada, Suguru, Tsutomu Fujii, Yukihiro Yokoyama, et al.. (2018). Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 81(5). 815–821. 20 indexed citations
3.
Yamada, Suguru, Fuminori Sonohara, Hideki Takami, et al.. (2018). Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer. Annals of Surgical Oncology. 25(11). 3365–3371. 30 indexed citations
4.
Yamada, Suguru, Tsutomu Fujii, Nao Takano, et al.. (2018). Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.. Journal of Clinical Oncology. 36(4_suppl). 523–523. 2 indexed citations
5.
Yamada, Suguru, Tsutomu Fujii, Akihiro Hirakawa, et al.. (2018). Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms. Pancreas. 47(8). 974–979. 23 indexed citations
6.
Kato, Yoshiyasu, Suguru Yamada, Masaya Suenaga, et al.. (2018). Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma. Pancreas. 47(7). 823–829. 41 indexed citations
7.
Yamada, Suguru, Fuminori Sonohara, Masaya Suenaga, et al.. (2018). Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer. Scientific Reports. 8(1). 9846–9846. 27 indexed citations
8.
Shimizu, Dai, Mitsuro Kanda, Haruyoshi Tanaka, et al.. (2017). GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer. Scientific Reports. 7(1). 42089–42089. 28 indexed citations
9.
Kanda, Mitsuro, Yuri Tanaka, Chie Tanaka, et al.. (2017). Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World Journal of Gastroenterology. 23(14). 2519–2519. 46 indexed citations
10.
Umeda, Shinichi, Mitsuro Kanda, Hiroyuki Sugimoto, et al.. (2017). Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma. BMC Cancer. 17(1). 610–610. 12 indexed citations
11.
Hara, Kazuhiro, Yoshinao Muro, Yukiko Niwa, et al.. (2016). HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology. 87(8). 841–843. 12 indexed citations
12.
Inoue, Takayuki, Satoru Ito, Masahiko Ando, et al.. (2016). Changes in exercise capacity, muscle strength, and health-related quality of life in esophageal cancer patients undergoing esophagectomy. BMC Sports Science Medicine and Rehabilitation. 8(1). 34–34. 24 indexed citations
13.
Tanaka, Haruyoshi, Mitsuro Kanda, Dai Shimizu, et al.. (2016). FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer. Annals of Surgical Oncology. 24(11). 3438–3445. 24 indexed citations
14.
Niwa, Yukiko, Masahiko Koike, Masashi Hattori, et al.. (2016). Short-term outcomes after conventional transthoracic esophagectomy.. PubMed. 78(1). 69–78. 6 indexed citations
15.
Kanda, Mitsuro, Dai Shimizu, Haruyoshi Tanaka, et al.. (2016). Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Annals of Surgery. 267(3). 495–503. 77 indexed citations
16.
Niwa, Yukiko, Masahiko Koike, Masashi Hattori, et al.. (2015). The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 23(2). 611–618. 19 indexed citations
17.
Niwa, Yukiko, Masahiko Koike, Hisaharu Oya, et al.. (2015). Combination of continuous paravertebral block and epidural anesthesia in postoperative pain control after esophagectomy. Esophagus. 13(1). 42–47. 9 indexed citations
18.
Shimizu, Dai, Tsutomu Fujii, Masaya Suenaga, et al.. (2014). A Case of Carcinoma of the Ampulla of Vater with Anomaly of the Portal Venous System: Prepancreatic Postduodenal Portal Vein. The Japanese Journal of Gastroenterological Surgery. 47(5). 275–280. 5 indexed citations
19.
Hibino, Soki, Mitsuro Kanda, Hisaharu Oya, et al.. (2013). Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Oncology Reports. 31(2). 693–700. 26 indexed citations
20.
Ozeki, Naoki, Takayuki Fukui, Yukiko Niwa, et al.. (2012). Lung Adenocarcinoma Coexistent with Pulmonary Non-tuberculous Mycobacteriosis. Haigan. 52(2). 238–241. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kohei Wakatsuki Breakdown of academic impact, for papers by Gerd Jomrich Breakdown of academic impact, for papers by Kojiro Eto Breakdown of academic impact, for papers by Faik G. Uzunoǧlu Breakdown of academic impact, for papers by Atsushi Takeno Breakdown of academic impact, for papers by Yohei Nagai Breakdown of academic impact, for papers by Yoshiaki Sugiura Breakdown of academic impact, for papers by Jorge Baixauli Breakdown of academic impact, for papers by Keijiro Nozawa Breakdown of academic impact, for papers by Pengfei Kong
Rankless by CCL
2026